CONCORDBIO / NSE / Biotechnology & Drugs
Concord Biotech
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High2,149.9
Target Low987.05
Target Mean2.25
Target Median56.25
Risk Metrics
Overall RiskHigh risk
Board Risk45.38
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Concord Biotech to host virtual analyst meet on June 17 scanx.trade
Concord Biotech Secures USFDA Approval for Tofacitinib Tablets, Targets USD 500 Million US Market Medical Dialogues
Brazilian Regulator Completes Inspection of Concord Biotech's Limbasi Facility marketscreener.com
Concord Biotech Completes ANVISA Inspection At Limbasi Facility; Shares Up Marginally HDFC Sky
CarTrade Tech, Concord Biotech, Apar Industries shares rise up to 8% today; here's why MSN
Reduce Concord Biotech Ltd for Target Rs.1,045 by Choice Institutional Equities Investment Guru
Concord Biotech, Carysil among top stocks to buy today; check targets Business Standard
Trade Spotlight: How should you trade Concord Biotech, Jindal Steel, Axis Bank, Aegis Logistics, Raymond,... Moneycontrol.com
© SharekeyX | Rusaka Technologies 2024-2026

